Detalhe da pesquisa
1.
Persistent immune-related adverse events after cessation of checkpoint inhibitor therapy: Prevalence and impact on patients' health-related quality of life.
Eur J Cancer
; 176: 88-99, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36198246
2.
Health-related quality of life (EuroQol 5D-5L) in patients with autoimmunity in the context of immunotherapy: A large dataset comprising cancer patients after cessation of checkpoint inhibitor therapy and patients with autoimmune diseases.
Data Brief
; 45: 108676, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36426068
3.
Development of Lymphopenia during Therapy with Immune Checkpoint Inhibitors Is Associated with Poor Outcome in Metastatic Cutaneous Melanoma.
Cancers (Basel)
; 14(13)2022 Jul 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35805052